Show ratings & reviews for

3.7 Overall Rating

Effectiveness

Ease of Use

Satisfaction

Most voted positive review

18 People found this comment helpful

I have suffered with RA for 27 years. I am currently 51. I have never had a day off from pain or experienced remission. The day Enbrel was FDA approved, I started the shots. Since then, I have tried (and failed) every single biologic from Remicaide to Xeljanz. I have had both wrists fused, one hand completely reconstructed, corneal melts, pleural effusion in both lungs, heart surgery to remove 2 l...

Most voted negative review

4 People found this comment helpful

I just started taking this medication last week. I have been receiving infusions(Actemera) for over 2 years now. I was doing ok on the infusions but my Dr. felt I have plateaued on the infusion treatment and wanted me to improve more. I am hoping this will improve my present condition to a higher level of functioning. Time will tell

Shared reviews and ratings

frustrated | 55-64 | Female | On medication for less than 1 month | Patient
12/18/2019
Condition: Rheumatoid Arthritis
Overall rating 2.3
Effectiveness
Ease of Use
Satisfaction

Causing bad headaches , still very achey not on it long. Hope it improves

Report this postFill 3Created with Sketch.
Janet | 55-64 | Female | On medication for less than 1 month | Patient
11/19/2019
Condition: Rheumatoid Arthritis
Overall rating 4.3
Effectiveness
Ease of Use
Satisfaction

Have been on it for less than a month, so far no side effects.

Report this postFill 3Created with Sketch.

IMPORTANT INFORMATION ABOUT USER-GENERATED CONTENT ON WEBMD

The opinions expressed in WebMD User-generated content areas like communities, reviews, ratings, or blogs are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. User-generated content areas are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions.

Read More